These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6964047)

  • 1. [Topical application of ACNU for the treatment of mycosis fungoides].
    Jimbow K; Horikoshi T; Kamimura M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of psoriasis. Critical study of the use of ACNU (nimustine hydrochloride)].
    Imaizumi T; Mitsuhashi Y; Katabira Y
    Ann Dermatol Venereol; 1986; 113(5):427-34. PubMed ID: 3472485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS; Epstein EH
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
    Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
    J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell subsets and NCI (nuclear contour index) of their skin infiltrates in mycosis fungoides (MF)--a comparison of pre-and post-treatments using ACNU [1-(4-amino-2 methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl-3-nitrosourea)] and interferon alpha and the effectiveness of interferon alpha on Sézary cells in vitro.
    Zhang KG; Iwahara K; Hantanyapong Y; Kiyohara A; Yaguchi H; Ogawa H
    J Dermatol; 1987 Apr; 14(2):150-7. PubMed ID: 3301961
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical carmustine (BCNU) for patch/plaque mycosis fungoides.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):202-6. PubMed ID: 7986689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
    Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
    Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic and biliary excretion of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) in man].
    Matsuno S; Kakizaki K; Sasaki K; Sato T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1486-90. PubMed ID: 6575728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
    Muraoka K
    No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
    Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
    Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
    Shimizu K; Ushio Y; Hayakawa T; Mogami H
    Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
    Volden G; Larsen TE
    Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemotherapy of Mycosis fungoides by interferon-alpha.
    Peycheva E; Daskalov I; Tsoneva I
    Bioelectrochemistry; 2007 May; 70(2):283-6. PubMed ID: 17150416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
    Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
    Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.